Infrared microspectroscopic analysis of bone tissue from animal models and humans at equivalent anatomical locations gave great insight to the role of bone quality in determining bone strength. It became feasible to conclusively show differences in bone mineral maturity between normal and osteoporotic bone at equivalent anatomical locations. Even more revealing was the analysis of the spatial variation in pyr and deH-DHLNL collagen cross-links in the same bones. It was shown that the ratio between these two major collagen cross-links was very different when osteoporotic and normal bones were compared in the area of trabecular bone with actively bone forming surfaces. These data are in excellent agreement with recently published clinical observations that homocysteine blood serum level were elevated in patients with increased fracture risk. It is interesting to note that these differences were also observed between normal, and bone biopsies obtained from pre-menopausal women sustaining spontaneous fractures while having normal BMD and biochemical markers, suggesting that this might be a common factor / cause of fragile bone.
The effect of therapeutic protocols on bone quality has also been investigated. During these studies, it was discovered that when fracture risk and BMD were divergent, both mineral maturity and pyr / deH- DHLNL collagen cross-link ratio was correlating with fracture risk rather than BMD, further emphasizing the contribution of bone quality to its mechanical performance.
Future directions
Since the introduction of the Infrared Microspectroscopic analysis in the early 1990′s, the debate rages whether it is a diagnostic tool. Although it provides a plethora of useful outcomes, it is our opinion that it is not well suited to be employed as a mass-screening tool, for the simple reason that it is an invasive technique as a bone biopsy is required. On the other hand, it is ideally suited for cases of fracturing patients whose “classical” risk indicators such as BMD and biochemical markers are normal.
On the other hand, it is a powerful research tool, affording unique insights into the pathophysiology of musculoskeletal diseases such as osteoporosis, osteogenesis imperfecta, Paget’s disease, osteomalacia, ostepetrosis, osteosclerosis, etc. Its outcomes complement ones obtained through analyses such as histology, histomorphometry, biochemical markers, blood analysis, and BMD measurements, to provide detailed information on the mechanisms that result in healthy and diseased bone.
…Read the rest of this article